A possible explanation for the discrepancy between ELISA and neutralising antibodies to tetanus toxin

Vaccine

Volumn 18, Issue 24, 2000, Pages 2698-2703

  Dokmetjian, J ^a   Della Valle, C ^a   Lavigne, V ^a   De Luján, Calcagno M ^a   Manghi, M A ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Antitetanus antibodies; Asymmetric IgG molecules; TNT ELISA ratio; Whole cell DTP vaccine

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; NEUTRALIZING ANTIBODY;

ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; INTERMETHOD COMPARISON; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 0034212499     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00066-9     Document Type: Article

References (27)

1. Heidelberger M., Kendall F.E. A quantitative theory of the precipiting reaction. The reaction between crystalline egg albumin and its antibody. J. Exp. Meth. 62:1935;697-700.
2. Margni R.A., Binaghi R.A. Purification and properties of non-precipitating rabbit antibodies. Immunology. 22:1972;557-563.
3. Margni R.A., Hajos S.E. Biological and physicochemical properties of purified anti-DNP guinea-pig non-precipitating antibodies. Immunology. 24:1973;435-443.
4. Margni R.A., Castrelos O.D., Paz C.B. The sheep immune response. Variations of anti-hapten and anti-carrier antibodies localized in the IgG1 and IgG2 immunoglobulins fractions. Immunology. 24:1973;781-789.
5. Margni R.A., Hajos S.E., Manghi M., Perdigón G., Leoni J. Red cell Fc receptors and their participation in the passive haemagglutination mediated by the non-precipitating antibodies. Immunology. 27:1974;863-870.
6. Margni R.A., Paz C.B., Cordal M.E. The behaviour of sheep non-precipitating antibodies isolated by immunoadsorption. Immunochemistry. 13:1976;209-214.
7. Margni R.A., Hajos S.E., Cordal M.E., Quiroga S. The hemagglutinating activity of different anti-DNP antibody populations when dinitrophenylated sheep and human red cells are used as agglutinogen. J. Immun. Meth. 13:1976;51-62.
8. Margni R.A., Binaghi R.A. Non-precipitating asymmetric antibodies. Ann. Rev. Immun. 6:1988;535-554.
9. Margni R.A. Coprecipitating IgG asymmetric antibodies: a possible role for Fab glycosylation and speculations on their formation and functions in disease. Glycosyl. Dis. 1:1994;59-66.
10. Labeta M., Margni R.A., Leoni J., Binaghi R.A. Structure of asymmetric non-precipitating antibody: presence of a carbohydrate residue in only one Fab region of the molecule. Immunology. 57:1986;311-317.
11. Leoni J., Labeta M., Margni R.A. The asymmetric IgG nonprecipitating antibody localization of the oligosaccharide involved in that phenomenon by ConA interaction. Mol. Immun. 23:1986;1397-1400.
12. Morelli L., Leoni J., Fossati C.A., Margni R.A. Symmetric and asymmetric IgG antibodies are synthesized by the same cellular clone. Mol. Immun. 26:1989;789-792.
13. Malán Borel I., Gentile T., Angelucci J., Margni R.A., Binaghi R.A. Asymmetrically glycosylated IgG isolated from non-immune sera. Biochem. Biophys. Acta. 990:1989;162-164.
14. Margni R.A., Parma E., Cerone S., Erpelding A., Perdigón G. Agglutinating and non-agglutinating antibodies in rabbits inoculated with a particulate antigen (Salmonella typhimurium). Immunology. 48:1983;351-359.
15. Margni R.A., Perdigón G., Gentile T., Dokmetjian J. IgG precipitating and coprecipitating antibodies in rabbits repeatedly injected with soluble and particulate antigens. Vet. Immun. Immunopath. 13:1986;51-61.
16. Dokmetjian J., Eriksson P., Della Valle M.C., Lavigne M.V., Manghi M.A. Relationship between structure and neutralising activity of rabbit tetanus antibodies elicited by acellular and whole-cell pertussis DTP vaccines. Vaccine. 16:1997;672-677.
17. Margni R, Malan Borel I. Role of asymmetric IgG antibodies in fetal maintenance, Current Trends Immun. 1999; (in press).
18. Pasetti M., Dokmetjian J., Brero M.L., Eriksson P.V., Ferrero F., Manghi M.A. Structure and protective capacity of tetanus and diphtheria antibodies produced during human pregnancy and transferred to new-born. Am. J. Rep. Immun. 37:1997;250-256.
19. Simonsen O., Bentzon M.W., Heron I. ELISA for the routine determination of antitoxic immunity to tetanus. J. Biol. Stand. 14:1986;231-239.
20. Simonsen O., Schou C., Heron I. Modification of the ELISA for the estimation of tetanus antitoxin in human sera. J. Biol. Stand. 15:1987;143-157.
21. Craig J.P. Immune response to Corynebacterium diphtheriae and Clostridium tetani: diagnostic method. Rose N.R., Conway de Macario E., Fahey J.L., Friedman H., Penn G.M. Manual of laboratory immunology. 4th ed. 1992;435-439 American Society for Microbiology, Washington DC.
22. Finney D.J. Statistical methods in biological assay. 1964;33 Charles Griffin, London. chapter 20.
23. Harlow E, Lane D. Storing and purifying antibodies. In: Antibodies: a laboratory manual, ch. 8. New York: Cold Spring Harbor Laboratory, 1988. p. 309-11.
24. Natvig J.B., Turner M.W. Pepsin digestion of human G-myeloma proteins of different subclasses. II. Immunochemical investigations of the products of peptic digestion. Clin. Exp. Immun. 7:1970;627-640.
25. Plotkin S.A., Ornstein W.A. Vaccines. 3rd ed. 1999;441-474 Saunders, Philadelphia, PA. chapter 18.
26. Crone E.N., Reder A.T. Severe tetanus in immunized patients with high antitetanus titers. Neurology. 42:1992;761-764.
27. Moraes-Pinto de M.I., Oruamabo R.S., Igbagiri F.P., Chan M.C.K., Prado S.M.A., Vancetto M.D.C., Johnson P.M., Hart C.A. Neonatal tetanus despite immunization and protective antitoxin antibody. J. Infect. Dis. 171:1995;1076-1077.